Header image

Session 11C: Lab - Orbit - Factory: How space enables new commercialisation pathways

Tracks
Track 3
Friday, October 23, 2026
1:10 PM - 1:55 PM
Discovery & Advanced Therapeutics Breakout Room

Overview

Sponsored by: OUTLIER SPACE


Details

Bringing a new therapy to market is highly challenging, requiring years of R&D, billions in investment, and absorbing failures that often trace back to problems identified too late. Space changes the odds. In microgravity, biology behaves differently. Molecules form orderly structures, cells grow and age faster, and answers arrive sooner. This enables sharper discovery, fewer late-stage surprises, and entirely new ways to manufacture and reformulate drugs and treatments that cannot be replicated on Earth. From the laboratory to orbit to the production line, this panel brings industry leaders together to map the commercial pathways space is opening today, details how industry and researchers can benefit, and provides unique insights into one of the fastest developing innovations in the biotech world. Sponsored by:


Speaker

Agenda Item Image
Associate Professor Sarah Kessans
Associate Professor and Founder
University of Canterbury and Reciprocal Space Limited

Panellist

Ms Rebecca Lee
Managing Director
Merck Life Science

Panellist

Agenda Item Image
Mr Alexander Linossier
Head Of Customer
Outlier Space

Chair

Agenda Item Image
Ms Jackie Vullinghs
Partner
Airtree

Panellist

loading